iifl-logo

Akums Drugs & Pharmaceuticals Ltd AGM

480.35
(-2.13%)
Aug 8, 2025|12:00:00 AM

CORPORATE ACTIONS

08/08/2024calendar-icon
08/08/2025calendar-icon
PurposeAGM DateAnnouncement Date
AGM18 Jul 202526 May 2025
Notice of 21st Annual General Meeting (AGM) of the Company which is scheduled to be held on Friday, 18th July, 2025 at 11:00 AM IST through Video Conferencing/Other Audio-Visual Means. The notice convening the AGM along with the Integrated Annual Report for the financial year ended 31st March, 2025, will be sent in due course. Intimation of Approval of revised Notice of AGM (As Per BSE Announcement Dated on :07.06.2025) Business Responsibility and Sustainability Report for the Financial Year Ended 31.03.2025. Notice convening 21st Annual General Meeting and Intergrated Annual Report of Financial Year 2024-25 (As Per BSE Announcement Dated on 24/06/2025) Proceedings of 21st Annual General Meeting (As per BSE Announcement Dated on 18.07.2025) Scrutinizers Report of 21st Annual General Meeting (As Per BSE Announcement Dated on: 19/07/2025)

Akums Drugs & Pharmaceuticals Ltd: Related News

Akums Drugs & Pharm a shares close at a 17% premium
6 Aug 2024|03:43 PM

The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.

Read More
Akums Drugs Lists With 6% Premium
6 Aug 2024|09:56 AM

The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.

Read More
Akums Drugs & Pharma IPO subscribed 43 times so far
1 Aug 2024|03:26 PM

The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.

Read More
Akums Drugs IPO Subscribed 3.20 times so far Day 2
31 Jul 2024|03:48 PM

On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.

Read More
Akums Drugs and Pharmaceuticals IPO subscribed 97%
30 Jul 2024|03:09 PM

The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.